Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LORIS 2% CHG WIPE/SERVIETTE - Health Canada Drug Approval Details

Approvals/Health Canada/LORIS 2% CHG WIPE/SERVIETTE

Authorized

STANDARD

LORIS 2% CHG WIPE/SERVIETTE

lernapharm (loris) inc.🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 43a403719824ced3
Company: lernapharm (loris) inc.
Type: Standard

Approval Details

Approval Id: 43a403719824ced3
Drug Approval Canada Name: LORIS 2% CHG WIPE/SERVIETTE
Product Name: LORIS 2% CHG WIPE/SERVIETTE
Status: Marketed
Status Date: 2016-10-07
Original Market Date: 2016-10-07
Din: 02355965
Drug Class: Human
Dosage Form: Wipe
Route Of Administration: Topical (Household)
Schedule: OTC
Ahfs: 84:04.92
Atc Original: D08AC02 CHLORHEXIDINE
Atc Name: d 08 ac 02
Aig Number: 0107629004
Company Name: lernapharm (loris) inc.
Company Address: 2323 Rue Halpern, St-Laurent, Quebec, Canada, H4S 1S3

Active Ingredients

CHLORHEXIDINE GLUCONATE

2 % / W/V

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

43a403719824ced3

Type

Standard

Back to Health Canada Approvals